Cargando…

Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application

INTRODUCTION: Hypoglycaemia is a frequent adverse event and major barrier for achieving optimal blood glucose levels in people with type 1 or type 2 diabetes using insulin. The Hypo-RESOLVE (Hypoglycaemia—Redefining SOLutions for better liVEs) consortium aims to further our understanding of the day-...

Descripción completa

Detalles Bibliográficos
Autores principales: Søholm, Uffe, Broadley, Melanie, Zaremba, Natalie, Divilly, Patrick, Nefs, Giesje, Mahmoudi, Zeinab, de Galan, Bastiaan, Pedersen-Bjergaard, Ulrik, Brennan, Alan, Pollard, Daniel John, McCrimmon, Rory J, A. Amiel, Stephanie, Hendrieckx, Christel, Speight, Jane, Choudhary, Pratik, Pouwer, Frans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808414/
https://www.ncbi.nlm.nih.gov/pubmed/35105572
http://dx.doi.org/10.1136/bmjopen-2021-051651
_version_ 1784643882317774848
author Søholm, Uffe
Broadley, Melanie
Zaremba, Natalie
Divilly, Patrick
Nefs, Giesje
Mahmoudi, Zeinab
de Galan, Bastiaan
Pedersen-Bjergaard, Ulrik
Brennan, Alan
Pollard, Daniel John
McCrimmon, Rory J
A. Amiel, Stephanie
Hendrieckx, Christel
Speight, Jane
Choudhary, Pratik
Pouwer, Frans
author_facet Søholm, Uffe
Broadley, Melanie
Zaremba, Natalie
Divilly, Patrick
Nefs, Giesje
Mahmoudi, Zeinab
de Galan, Bastiaan
Pedersen-Bjergaard, Ulrik
Brennan, Alan
Pollard, Daniel John
McCrimmon, Rory J
A. Amiel, Stephanie
Hendrieckx, Christel
Speight, Jane
Choudhary, Pratik
Pouwer, Frans
author_sort Søholm, Uffe
collection PubMed
description INTRODUCTION: Hypoglycaemia is a frequent adverse event and major barrier for achieving optimal blood glucose levels in people with type 1 or type 2 diabetes using insulin. The Hypo-RESOLVE (Hypoglycaemia—Redefining SOLutions for better liVEs) consortium aims to further our understanding of the day-to-day impact of hypoglycaemia. The Hypo-METRICS (Hypoglycaemia—MEasurement, ThResholds and ImpaCtS) application (app) is a novel app for smartphones. This app is developed as part of the Hypo-RESOLVE project, using ecological momentary assessment methods that will minimise recall bias and allow for robust investigation of the day-to-day impact of hypoglycaemia. In this paper, the development and planned psychometric analyses of the app are described. METHODS AND ANALYSIS: The three phases of development of the Hypo-METRICS app are: (1) establish a working group—comprising diabetologists, psychologists and people with diabetes—to define the problem and identify relevant areas of daily functioning; (2) develop app items, with user-testing, and implement into the app platform; and (3) plan a large-scale, multicountry study including interviews with users and psychometric validation. The app includes 7 modules (29 unique items) assessing: self-report of hypoglycaemic episodes (during the day and night, respectively), sleep quality, well-being/cognitive function, social interactions, fear of hypoglycaemia/hyperglycaemia and work/productivity. The app is designed for use within three fixed time intervals per day (morning, afternoon and evening). The first version was released mid-2020 for use (in conjunction with continuous glucose monitoring and activity tracking) in the Hypo-METRICS study; an international observational longitudinal study. As part of this study, semistructured user-experience interviews and psychometric analyses will be conducted. ETHICS AND DISSEMINATION: Use of the novel Hypo-METRICS app in a multicountry clinical study has received ethical approval in each of the five countries involved (Oxford B Research Ethics Committee, CMO Region Arnhem-Nijmegen, Ethikkommission der Medizinischen Universität Graz, Videnskabsetisk Komite for Region Hovedstaden and the Comite Die Protection Des Personnes SUD Mediterranne IV). The results from the study will be published in peer review journals and presented at national and international conferences. TRIAL REGISTRATION NUMBER: NCT04304963.
format Online
Article
Text
id pubmed-8808414
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88084142022-02-09 Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application Søholm, Uffe Broadley, Melanie Zaremba, Natalie Divilly, Patrick Nefs, Giesje Mahmoudi, Zeinab de Galan, Bastiaan Pedersen-Bjergaard, Ulrik Brennan, Alan Pollard, Daniel John McCrimmon, Rory J A. Amiel, Stephanie Hendrieckx, Christel Speight, Jane Choudhary, Pratik Pouwer, Frans BMJ Open Diabetes and Endocrinology INTRODUCTION: Hypoglycaemia is a frequent adverse event and major barrier for achieving optimal blood glucose levels in people with type 1 or type 2 diabetes using insulin. The Hypo-RESOLVE (Hypoglycaemia—Redefining SOLutions for better liVEs) consortium aims to further our understanding of the day-to-day impact of hypoglycaemia. The Hypo-METRICS (Hypoglycaemia—MEasurement, ThResholds and ImpaCtS) application (app) is a novel app for smartphones. This app is developed as part of the Hypo-RESOLVE project, using ecological momentary assessment methods that will minimise recall bias and allow for robust investigation of the day-to-day impact of hypoglycaemia. In this paper, the development and planned psychometric analyses of the app are described. METHODS AND ANALYSIS: The three phases of development of the Hypo-METRICS app are: (1) establish a working group—comprising diabetologists, psychologists and people with diabetes—to define the problem and identify relevant areas of daily functioning; (2) develop app items, with user-testing, and implement into the app platform; and (3) plan a large-scale, multicountry study including interviews with users and psychometric validation. The app includes 7 modules (29 unique items) assessing: self-report of hypoglycaemic episodes (during the day and night, respectively), sleep quality, well-being/cognitive function, social interactions, fear of hypoglycaemia/hyperglycaemia and work/productivity. The app is designed for use within three fixed time intervals per day (morning, afternoon and evening). The first version was released mid-2020 for use (in conjunction with continuous glucose monitoring and activity tracking) in the Hypo-METRICS study; an international observational longitudinal study. As part of this study, semistructured user-experience interviews and psychometric analyses will be conducted. ETHICS AND DISSEMINATION: Use of the novel Hypo-METRICS app in a multicountry clinical study has received ethical approval in each of the five countries involved (Oxford B Research Ethics Committee, CMO Region Arnhem-Nijmegen, Ethikkommission der Medizinischen Universität Graz, Videnskabsetisk Komite for Region Hovedstaden and the Comite Die Protection Des Personnes SUD Mediterranne IV). The results from the study will be published in peer review journals and presented at national and international conferences. TRIAL REGISTRATION NUMBER: NCT04304963. BMJ Publishing Group 2022-02-01 /pmc/articles/PMC8808414/ /pubmed/35105572 http://dx.doi.org/10.1136/bmjopen-2021-051651 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Diabetes and Endocrinology
Søholm, Uffe
Broadley, Melanie
Zaremba, Natalie
Divilly, Patrick
Nefs, Giesje
Mahmoudi, Zeinab
de Galan, Bastiaan
Pedersen-Bjergaard, Ulrik
Brennan, Alan
Pollard, Daniel John
McCrimmon, Rory J
A. Amiel, Stephanie
Hendrieckx, Christel
Speight, Jane
Choudhary, Pratik
Pouwer, Frans
Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application
title Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application
title_full Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application
title_fullStr Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application
title_full_unstemmed Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application
title_short Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application
title_sort investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the hypo-metrics application
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808414/
https://www.ncbi.nlm.nih.gov/pubmed/35105572
http://dx.doi.org/10.1136/bmjopen-2021-051651
work_keys_str_mv AT søholmuffe investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT broadleymelanie investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT zarembanatalie investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT divillypatrick investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT nefsgiesje investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT mahmoudizeinab investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT degalanbastiaan investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT pedersenbjergaardulrik investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT brennanalan investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT pollarddanieljohn investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT mccrimmonroryj investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT aamielstephanie investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT hendrieckxchristel investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT speightjane investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT choudharypratik investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT pouwerfrans investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication
AT investigatingthedaytodayimpactofhypoglycaemiainadultswithtype1ortype2diabetesdesignandvalidationprotocolofthehypometricsapplication